Overall, we here demonstrate that ACM polymersome nanocarriers efficiently target antigen‐presenting cells and promote the generation of tumour‐specific CD8+ effector T cells, resulting in effective anti‐tumour immune responses, tumour regression and prolonged survival of mice. The gene discussed is CD8A; the disease is neoplasm.